What is the clinical evidence from this study?

Study design: Cross-Sectional. Population: Hypertension (n=28666). Intervention: Time period (2021-2023) vs. Time period (2001-2004). Primary outcome: Overall central obesity prevalence (p=<0.001).

What question did this study set out to answer?

To analyze long-term trends in the prevalence of central obesity among adults with hypertension in the U.S.

April 15, 2026Journal of Clinical HypertensionOpen Access

Trends in Central Obesity Prevalence Among Adults With Hypertension in the United States, 2001–2023

Q: What are the key findings of this study?

The 2021-2023 survey period was associated with a significantly higher prevalence of central obesity among US hypertensive adults compared to 2001-2004 (69.7% vs 59.2%, p<0.001).

Q: What question did this study set out to answer?

To analyze long-term trends in the prevalence of central obesity among adults with hypertension in the U.S.

View Full Paper

Ask AI

Bookmark

Key result

Central obesity prevalence in US hypertensive adults rose ~18% from 2001-2004 to 2021-2023.

P<0.001
n=28,666

Key Points

To analyze long-term trends in the prevalence of central obesity among adults with hypertension in the U.S.
Analyzed data from National Health and Nutrition Examination Survey (NHANES) from 2001-2023.
Included 28,666 adult participants with hypertension.
Defined central obesity based on waist circumference and categorized it into severity grades.
Applied Joinpoint software to analyze age-standardized prevalence trends.
Overall central obesity prevalence increased from 59.2% (2001-2004) to 69.7% (2021-2023, p < 0.001).
Female prevalence was higher than males, with rates rising from 72.2% to 80.5% and from 49.2% to 61.3%, respectively.
Severe (Grade III) obesity prevalence jumped from 20.1% to 30.9% (p < 0.001).
The 20-44 age group experienced the largest increase in prevalence from 50.5% to 66.1%, contributing significantly to the overall rise.

Study Design

Type

Cross-Sectional (n=28,666)

Multicenter

Yes

Structured PICO

Population

28,666 adult hypertensive participants from the US NHANES database evaluated for central obesity trends between 2001 and 2023.

Outcome

Age-standardized prevalence trends of central obesity (waist circumference ≥102 cm for men or ≥88 cm for women) and its severity grades

Main Result

Absolute Event Rate: 69.7% vs 59.2%

p-value: p=<0.001

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

The prevalence of central obesity, especially severe forms, has significantly increased among US adults with hypertension over the past two decades, with the largest absolute increase seen in younger adults.

Cite This Study

Lin et al. (2026) conducted a cross-sectional in Hypertension (n=28,666). Time period (2021-2023) vs. Time period (2001-2004) was evaluated on Overall central obesity prevalence (p=<0.001). The 2021-2023 survey period was associated with a significantly higher prevalence of central obesity among US hypertensive adults compared to 2001-2004 (69.7% vs 59.2%, p<0.001).

synapsesocial.com/papers/69df2b2ce4eeef8a2a6b00e6 https://doi.org/10.1111/jch.70252

View Full Paper

Ask AI

Bookmark

Trends in Central Obesity Prevalence Among Adults With Hypertension in the United States, 2001–2023

Key Points

Study Design

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Trends in Central Obesity Prevalence Among Adults With Hypertension in the United States, 2001–2023

Key Points

Study Design

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Also Consider

Also Consider